BioCentury | Aug 11, 2005
Financial News

Avontec raises EUR 14.5 million

...and DVC Deutsche Venture Capital. New investors BioMedinvest and KfW joined InnovationsKapital; UBG Goettingen-Hildesheim; and Mediport...
BioCentury | Feb 23, 2004
Emerging Company Profile

Corporate Profile

...employees: 8 Funds raised: E5.5 million ($6.4 million) Investors: DVC Deutsche Venture Capital; Innovations-Capital Goettingen; Mediport...
BioCentury | Jan 12, 2004
Emerging Company Profile

Corporate Profile

...Charité, and Medical Shool Hannover Employees: 26 Funds raised: $4.7 million Investors: Encysive Pharmaceuticals Inc.; Mediport...
BioCentury | Aug 1, 2000
Financial News

Texas Biotech funds Berlin subsidiary

...owned subsidiary, Revotar Biopharmaceuticals, raised DM10 million ($4.7 million) through equity investments from BMP and Mediport...
Items per page:
1 - 4 of 4
BioCentury | Aug 11, 2005
Financial News

Avontec raises EUR 14.5 million

...and DVC Deutsche Venture Capital. New investors BioMedinvest and KfW joined InnovationsKapital; UBG Goettingen-Hildesheim; and Mediport...
BioCentury | Feb 23, 2004
Emerging Company Profile

Corporate Profile

...employees: 8 Funds raised: E5.5 million ($6.4 million) Investors: DVC Deutsche Venture Capital; Innovations-Capital Goettingen; Mediport...
BioCentury | Jan 12, 2004
Emerging Company Profile

Corporate Profile

...Charité, and Medical Shool Hannover Employees: 26 Funds raised: $4.7 million Investors: Encysive Pharmaceuticals Inc.; Mediport...
BioCentury | Aug 1, 2000
Financial News

Texas Biotech funds Berlin subsidiary

...owned subsidiary, Revotar Biopharmaceuticals, raised DM10 million ($4.7 million) through equity investments from BMP and Mediport...
Items per page:
1 - 4 of 4